Ewa Orlewska: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

An ecological study of the link between the risk of most frequent types of cancer in Poland and socioeconomic variables

Orlewska, Katarzyna, Sliwczynski, Andrzej, Orlewska, Ewa

Journal:

International Journal of Public Health

Year:

2018

Language:

english

File:

PDF, 465 KB

english, 2018

2

Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis

Josephine A. Mauskopf, Sean D. Sullivan, Lieven Annemans, Jaime Caro, C. Daniel Mullins, Mark Nuijten, Ewa Orlewska, John Watkins, Paul Trueman

Journal:

Value in Health

Year:

2007

Language:

english

File:

PDF, 277 KB

english, 2007

3

Drug-class-specific changes in the volume and cost of antidiabetic medications in Poland between 2012 and 2015

Śliwczyński, Andrzej, Brzozowska, Melania, Jacyna, Andrzej, Iltchev, Petre, Iwańczuk, Tymoteusz, Wierzba, Waldemar, Marczak, Michał, Orlewska, Katarzyna, Szymański, Piotr, Orlewska, Ewa, Fürnsinn, Cle

Journal:

Year:

2017

Language:

english

File:

PDF, 1011 KB

english, 2017

4

Cost-effectiveness of somatostatin analogues in the treatment of acromegaly

Orlewska, Ewa, Stępień, Renata, Orlewska, Katarzyna

Journal:

Expert Review of Pharmacoeconomics & Outcomes Research

Year:

2018

Language:

english

File:

PDF, 918 KB

english, 2018

5

Analysis of the survival of patients receiving systemic treatment for melanoma of the skin: a retrospective population study with patients treated in Poland in 2011–2015

Brzozowska, Melania, Wierzba, Waldemar, Śliwczyński, Andrzej, Majkut, Gabriela, Jacyna, Andrzej, Orlewska, Ewa, Potemski, Piotr, Marczak, Michał

Journal:

Advances in Dermatology and Allergology

Year:

2019

File:

PDF, 269 KB

2019

6

Proposal of Polish Guidelines for Conducting Financial Analysis and Their Comparison to Existing Guidance on Budget Impact in Other Countries

Ewa Orlewska, Piotr Mierzejewski

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 94 KB

english, 2004

7

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

Sullivan, Sean D., Mauskopf, Josephine A., Augustovski, Federico, Jaime Caro, J., Lee, Karen M., Minchin, Mark, Orlewska, Ewa, Penna, Pete, Rodriguez Barrios, Jose-Manuel, Shau, Wen-Yi

Journal:

Value in Health

Year:

2014

Language:

english

File:

PDF, 575 KB

english, 2014

8

Reactivity of N 1 -Dithioester Substituted Pyridinand Pyrazincarboxamidrazones

Orlewska, Czeslawa, Pancechowska-Ksepko, Danuta, Foks, Henryk, Zwolska, Zofia, Augustynowicz-Kopec, Ewa

Journal:

Phosphorus Sulfur and Silicon and the Related Elements

Year:

2006

Language:

english

File:

PDF, 139 KB

english, 2006

9

Budget-Impact Analyses

Orlewska, Ewa, GulÃ¡csi, Laszlo

Journal:

PharmacoEconomics

Year:

2009

Language:

english

File:

PDF, 211 KB

english, 2009

10

Metabolic pathway of 4-pyridone-3-carboxamide-1β-D-ribonucleoside and its effects on cellular energetics

Pelikant-Malecka, Iwona, Kaniewska-Bednarczuk, Ewa, Szrok, Sylwia, Sielicka, Alicja, Śledziński, Maciej, Orlewska, Czesława, Smolenski, Ryszard T., Słomińska, Ewa M.

Journal:

The International Journal of Biochemistry & Cell Biology

Year:

2017

Language:

english

File:

PDF, 379 KB

english, 2017

11

In Vitro and Cellular Effects of 4-Pyridone-3-Carboxamide Riboside on Enzymes of Nucleotide Metabolism

Slominska, Ewa M., Borkowski, Tomasz, Rybakowska, Iwona, Abramowicz-Glinka, Magdalena, Orlewska, Czesława, Smolenski, Ryszard T.

Journal:

Nucleosides Nucleotides & Nucleic Acids

Year:

2014

Language:

english

File:

PDF, 227 KB

english, 2014

12

The Cost-Effectiveness of Alternative Therapeutic Strategies for the Management of Chronic Hepatitis B in Poland

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 147 KB

english, 2002

13

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in Patients with Acute Coronary Syndrome in Poland

Dr Ewa Orlewska,Andrzej Budaj,Dariusz Tereszkowski-Kaminski

Journal:

PharmacoEconomics

Year:

2003

Language:

english

File:

PDF, 140 KB

english, 2003

14

Cost-effectiveness of pegylated IFN-α 2b and - 2a and ribavirin for chronic hepatitis C treatment

Journal:

Expert Review of Pharmacoeconomics & Outcomes Research

Year:

2004

Language:

english

File:

PDF, 335 KB

english, 2004

15

Challenges and changes in the Polish healthcare system

Journal:

Society and Economy

Year:

2011

Language:

english

File:

PDF, 118 KB

english, 2011

16

Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland

W. Ken Redekop,Ewa Orlewska,Pawel Maciejewski,Frans F. H. Rutten…

Journal:

PharmacoEconomics

Year:

2008

Language:

english

File:

PDF, 201 KB

english, 2008

17

New insights into the burden and costs of multiple sclerosis in Europe: Results for Poland

Selmaj, Krzysztof, Kobelt, Gisela, Berg, Jenny, Orlewska, Ewa, Capsa, Daniela, Dalén, Johan

Journal:

Multiple Sclerosis Journal

Year:

2017

Language:

english

File:

PDF, 828 KB

english, 2017

18

Adherence to biologic DMARD therapies in rheumatoid arthritis

Koncz, Tamas, Pentek, Marta, Brodszky, Valentin, Ersek, Katalin, Orlewska, Ewa, Gulacsi, Laszlo

Journal:

Expert Opinion on Biological Therapy

Year:

2010

Language:

english

File:

PDF, 246 KB

english, 2010

19

Project of Polish Guidelines for Conducting Pharmacoeconomic Evaluations in Comparison to International Health Economic Guidelines

Ewa Orlewska and Piotr Mierzejewski

Journal:

The European Journal of Health Economics

Year:

2003

Language:

english

File:

PDF, 1.66 MB

english, 2003

20

LanroNET, a non-interventional, prospective study to assess the resource utilization and cost of lanreotide autogel 120 mg in Polish patients with neuroendocrine tumors – results of interim analysis

Orlewska, Ewa, Bednarczuk, Tomasz, Kaminski, Grzegorz, Kos-Kudla, Beata, group, LanroNET study

Journal:

Współczesna Onkologia

Year:

2014

Language:

english

File:

PDF, 81 KB

english, 2014

21

Project of Polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelines

Ewa Orlewska, Piotr Mierzejewski

Journal:

The European Journal of Health Economics

Year:

2003

Language:

english

File:

PDF, 195 KB

english, 2003

22

Burden of cancer in Poland analysed using potential years of life lost

Orlewska, Katarzyna, StÄpieÅ, Renata, Orlewska, Ewa

Journal:

Współczesna Onkologia

Year:

2020

File:

PDF, 60 KB

2020

23

Economic burden of multiple sclerosis: what can we learn from cost-of-illness studies?

Journal:

Expert Review of Pharmacoeconomics & Outcomes Research

Year:

2006

Language:

english

File:

PDF, 107 KB

english, 2006

24

P3-147: Budget impact analysis of erlotinib in the treatment of advanced non–small–cell lung cancer (NSCLC) in Poland

Orlewska, Ewa, Szczêsna, Aleksandra, Szkultecka-Dêbek, Monika

Journal:

Journal of Thoracic Oncology

Year:

2007

Language:

english

File:

PDF, 164 KB

english, 2007

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски